The IMID Forum

The IMID Forum

Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.

Denne podkasten er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(415)

Author Interview: Professor Valentino Paci, April 2026

Author Interview: Professor Valentino Paci, April 2026

Join Professor Peter Nash from the Griffith University in Brisbane, and am Professor Valentino Paci, Medical researcher specialized in immune-mediated diseases, with a particular focus on spondyloarth...

30 Apr 40min

Discussing RA: Updated EULAR recommendations and next-step strategies after TNF inhibitor failure

Discussing RA: Updated EULAR recommendations and next-step strategies after TNF inhibitor failure

Join Professor Iain McInnes and Professor Rieke Alten for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, they will review a paper by Smolen et ...

30 Apr 14min

Discussing PsA: Bimekizumab in PsA: Clinical efficacy and updated safety profile

Discussing PsA: Bimekizumab in PsA: Clinical efficacy and updated safety profile

Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘safety and clinical efficacy of bimekizumab in patient...

14 Apr 16min

Author Interview: Professor Helena Marzo-Ortega, March 2026

Author Interview: Professor Helena Marzo-Ortega, March 2026

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Helena Marzo-Ortega an academic clinician and the Clinical Lead of the multi-award winning Leeds Specialist Spondyloar...

9 Apr 37min

Discussing RA: Malignancy risk in patients with RA and the evolution of JAKi prescriptions

Discussing RA: Malignancy risk in patients with RA and the evolution of JAKi prescriptions

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review a paper a paper on the malignancy risk in patient...

26 Mar 10min

Discussing axSpA: Symptom duration impact on bimekizumab efficacy and therapeutic switching drivers

Discussing axSpA: Symptom duration impact on bimekizumab efficacy and therapeutic switching drivers

Join Dr Sofia Ramiro and Dr Atul Dheodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered the impact of shorter versus longer symptom duration on the e...

19 Mar 33min

Author Interview: Doctor Carlo Tur, February 2026

Author Interview: Doctor Carlo Tur, February 2026

Join Professor Peter Nash from the Griffith University in Brisbane, and Doctor Carlo Tur, from the department of Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University, Erlangen-Nurnbe...

12 Mar 29min

Author Interview - Professor Andrew Cope, 2026

Author Interview - Professor Andrew Cope, 2026

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Andrew Cope from the Centre for Rheumatic Diseases, King’s College London, London, UK, as they discuss his recent pape...

5 Mar 24min

Populært innen Fakta

fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
foreldreradet
treningspodden
jakt-og-fiskepodden
rss-orjasater
rss-kunsten-a-leve
rss-strid-de-norske-borgerkrigene
mikkels-paskenotter
tomprat-med-gunnar-tjomlid
sinnsyn
hverdagspsyken
fryktlos
rss-var-forste-kaffe
gravid-uke-for-uke
hagespiren-podcast
rss-impressions-2
smart-forklart
kvallm